LESS Surgery Versus Conventional Multiport Laparoscopy in Ovarian Drilling
Launched by AIN SHAMS MATERNITY HOSPITAL · Jun 30, 2017
Trial Information
Current as of July 02, 2025
Completed
Keywords
ClinConnect Summary
Laparoendoscopic single-site surgery; one of the most recent advances in the field of minimally invasive surgery, is the use of a single incision in the umbilicus for laparoscopic surgeries, is compared to the conventional multi-port laparoscopy for polycystic ovary syndrome in infertile women undergoing ovarian drilling as regards successful surgical procedure without conversion to laparotomy or use of an additional port in the single site group. in addition to operative time, intra- and post- operative complications and cosmetic outcome.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- * PCOS according to Rotterdam Criteria (2 out of 3):
- • polycystic ovaries (12 or more follicles in each ovary and/or increased ovarian volume \>10 cm3).
- • oligo- or an-ovulation.
- • clinical and/or biochemical hyperandrogenisim. After exclusion of other aetiologies for irregular cycles.
- * Indications of laparoscopic ovarian drilling:
- • clomiphene citrate- resistance or failure: failure to conceive after 6 to 9 cycles.
- • other indications for laparoscopy.
- • before gonadotropin administration to decrease risk of OHSS and multiple pregnancy.
- • before ART to decrease risk of severe OHSS in women who previously had canceled IVF cycles due to OHSS risk or who suffered from OHSS in a previous treatment.
- Exclusion Criteria:
- • previous 2 or more laparotomies.
- • chronic pelvic pain, endometriosis or pelvic inflammatory diseases to avoid pelvic adhesions and bias in the quantification of postoperative pain.
- • High BMI (\>35kg/m2)
- • do not possess a native umbilicus.
- • advanced gynaecological surgeries or malignant disorders (TLH, ALVH, laparoscopic myomectomy).
- • contraindication to any laparoscopy like any medical condition worsened by pneumoperitoneum or Trendelnburg position.
About Ain Shams Maternity Hospital
Ain Shams Maternity Hospital is a leading healthcare institution dedicated to providing comprehensive maternal and neonatal care. With a commitment to advancing women's health, the hospital engages in innovative clinical research and trials aimed at improving treatment outcomes and enhancing patient care. Equipped with state-of-the-art facilities and a team of experienced healthcare professionals, Ain Shams Maternity Hospital fosters a collaborative environment for research that prioritizes safety, efficacy, and ethical standards. Through its clinical trials, the hospital seeks to contribute to the global body of knowledge in obstetrics and gynecology, ultimately benefiting patients and healthcare providers alike.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Hesham M. Fathy, MD
Study Chair
Ain Shams University
Ahmed M. Bahaa Eldin, MD
Study Director
Ain Shams University
Haitham Fathy M., MD
Principal Investigator
Ain Shams University
Maya M. AbdelRazek, M. Sc.
Principal Investigator
Ain Shams University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials